Overview

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain

Status:
Withdrawn
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety, pharmacokinetics (PK), and efficacy of intravenous (IV) buprenorphine in pediatric patients.
Phase:
Phase 3
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Analgesics, Opioid
Buprenorphine